Retatrutide 20mg

Description

Retatrutide 20mg is a research-grade synthetic
peptide available in Canada from Verified Peptides.

Retatrutide is a triple hormone receptor agonist
that targets GIP, GLP-1, and glucagon receptors
simultaneously. Retatrutide peptide Canada
researchers have shown significant interest in
this compound for its role in metabolic regulation
and obesity research.

This compound has been extensively studied in
relation to glucose metabolism, insulin secretion,
energy homeostasis, and adipose tissue regulation
in laboratory settings. As a triple agonist, it
represents one of the most advanced research
tools available for metabolic pathway studies.

Each vial contains 20mg of Retatrutide with 99%+
purity, independently verified by Janoshik
third-party laboratory testing. Our Retatrutide
is manufactured under strict quality control
standards and supplied exclusively for in-vitro
and laboratory research purposes.

Scientists continue to investigate its role in
various biological processes including GLP-1
receptor activation, GIP receptor signaling,
and glucagon pathway regulation in laboratory
settings. Research into Retatrutide has expanded
significantly over the past few years.

Verified Peptides Canada is committed to supplying
the highest quality research peptides to the
scientific community across Canada. All orders
ship from Kingston, Ontario via Canada Post
with tracking provided.

Research Specifications:
– Purity: 99%+
– Format: Lyophilized powder
– Size: 20mg per vial
– Storage: Store at -20°C
– Type: Triple GIP/GLP-1/Glucagon Agonist
– Shipping: Canada-wide via Canada Post

Scientific literature on Retatrutide is available
at PubMed for researchers interested in its
mechanisms and biological activity.

Also available from Verified Peptides Canada:
Tirzepatide for GIP/GLP-1 research,
Semaglutide for GLP-1 receptor research, and
HGH Fragment 176-191 for metabolic research.

For research use only. Not for human consumption.
Shipped from Kingston, Ontario, Canada.